Back to Directory Michael McKenna Email michael.8.mckenna@gsk.com Phone 44 7557 290 283 Institution GSK Address GlaxoSmithKline Stockley Park West 1-3 Ironbridge Road Uxbridge Middlesex UB11 1BT , United Kingdom Request an Update Affiliated Studies IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Therapeutics Study Status Enrolling
IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Therapeutics Study Status Enrolling